How is Unverricht-Lundborg Disease diagnosed?

Unverricht-Lundborg disease is primarily diagnosed through clinical observation of progressive myoclonus epilepsy, followed by definitive confirmation via genetic testing to identify mutations in the CSTB gene. While symptoms typically emerge between the ages of 6 and 15, the diagnostic process requires specialized neurological assessment to distinguish it from other forms of progressive myoclonic epilepsy.

How is Unverricht-Lundborg disease diagnosed?

The diagnostic journey for Unverricht-Lundborg disease often begins with a neurologist evaluating a patient presenting with stimulus-sensitive myoclonus and tonic-clonic seizures. Because Unverricht-Lundborg disease is rare, it is common for patients to experience a "diagnostic odyssey," sometimes waiting years for a correct diagnosis as doctors rule out more common epilepsy syndromes. Diagnosis is confirmed by demonstrating biallelic mutations in the CSTB gene, which codes for the protein cystatin B.

What tests confirm Unverricht-Lundborg disease?

Clinicians utilize a combination of clinical, electrophysiological, and molecular assessments to identify Unverricht-Lundborg disease. Key diagnostic tools include:

• Genetic Testing: The gold standard for confirming Unverricht-Lundborg disease via molecular analysis of the CSTB gene.


• Electroencephalogram (EEG): Typically shows generalized polyspike-and-wave discharges, often triggered by photic stimulation.


• Clinical Examination: Evaluating the presence of action-induced myoclonus, which is a hallmark feature of the condition.


• MRI Imaging: Often appears normal in early stages, which helps clinicians differentiate Unverricht-Lundborg disease from neurodegenerative conditions that show structural brain atrophy.

Which specialists are involved in the diagnosis?

Given the complexity of Unverricht-Lundborg disease, patients are best served by a multidisciplinary team including an epileptologist, a clinical geneticist, and a neurologist specializing in movement disorders. Because many general practitioners are unfamiliar with this rare condition, seeking care at an academic medical center or a specialized epilepsy clinic is crucial for an accurate and timely diagnosis.

What is the differential diagnosis?

Medical professionals must distinguish Unverricht-Lundborg disease from other progressive myoclonic epilepsies, such as Lafora body disease, sialidosis, and neuronal ceroid lipofuscinoses. Misdiagnosis is a significant source of frustration for our 19 community members at DiseaseMaps.org, and it is important to remember that your experience of uncertainty is a common, valid response to the complexities of rare disease identification.

Next steps

• Consult with a board-certified epileptologist or a geneticist to discuss genetic panel testing.


• Request a referral to a center of excellence for rare neurological disorders.


• Connect with the DiseaseMaps.org community to share experiences with those who have navigated the path to diagnosis.

Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Unverricht-Lundborg disease overview.


• Orphanet: Rare disease database entry for Progressive Myoclonic Epilepsy type 1.


• OMIM (Online Mendelian Inheritance in Man): Entry #254800, Cystatin B.


• PubMed: Clinical reviews on the diagnostic utility of CSTB gene mutation analysis.